RUMBLEON INC-B (RMBL)

US7813863054 - Common Stock

5.89  +0.24 (+4.25%)

Fundamental Rating

2

Overall RMBL gets a fundamental rating of 2 out of 10. We evaluated RMBL against 121 industry peers in the Specialty Retail industry. RMBL has a bad profitability rating. Also its financial health evaluation is rather negative. RMBL is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

RMBL had negative earnings in the past year.
In the past year RMBL had a positive cash flow from operations.
RMBL had negative earnings in each of the past 5 years.
In the past 5 years RMBL reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -22.97%, RMBL is doing worse than 84.17% of the companies in the same industry.
RMBL's Return On Equity of -228.96% is on the low side compared to the rest of the industry. RMBL is outperformed by 80.83% of its industry peers.
With a Return On Invested Capital value of 1.73%, RMBL perfoms like the industry average, outperforming 44.17% of the companies in the same industry.
Industry RankSector Rank
ROA -22.97%
ROE -228.96%
ROIC 1.73%
ROA(3y)-16.56%
ROA(5y)-24.4%
ROE(3y)-111.09%
ROE(5y)-245.42%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of RMBL (1.26%) is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 25.43%, RMBL is doing worse than 75.83% of the companies in the same industry.
RMBL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.26%
PM (TTM) N/A
GM 25.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.21%
GM growth 5Y26.73%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RMBL is destroying value.
The number of shares outstanding for RMBL has been increased compared to 1 year ago.
Compared to 5 years ago, RMBL has more shares outstanding
Compared to 1 year ago, RMBL has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.77, we must say that RMBL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.77, RMBL is doing worse than 75.83% of the companies in the same industry.
The Debt to FCF ratio of RMBL is 12.06, which is on the high side as it means it would take RMBL, 12.06 years of fcf income to pay off all of its debts.
RMBL has a Debt to FCF ratio of 12.06. This is comparable to the rest of the industry: RMBL outperforms 50.83% of its industry peers.
RMBL has a Debt/Equity ratio of 5.43. This is a high value indicating a heavy dependency on external financing.
RMBL's Debt to Equity ratio of 5.43 is on the low side compared to the rest of the industry. RMBL is outperformed by 79.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.43
Debt/FCF 12.06
Altman-Z 0.77
ROIC/WACC0.17
WACC10.45%

2.3 Liquidity

RMBL has a Current Ratio of 1.12. This is a normal value and indicates that RMBL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.12, RMBL is not doing good in the industry: 69.17% of the companies in the same industry are doing better.
RMBL has a Quick Ratio of 1.12. This is a bad value and indicates that RMBL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.29, RMBL is doing worse than 75.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.29

4

3. Growth

3.1 Past

The earnings per share for RMBL have decreased strongly by -234.92% in the last year.
Looking at the last year, RMBL shows a decrease in Revenue. The Revenue has decreased by -8.86% in the last year.
The Revenue has been growing by 54.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-234.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.68%
Revenue 1Y (TTM)-8.86%
Revenue growth 3Y48.6%
Revenue growth 5Y54.27%
Sales Q2Q%-12.75%

3.2 Future

RMBL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.47% yearly.
The Revenue is expected to grow by 1.55% on average over the next years.
EPS Next Y91.06%
EPS Next 2Y40.96%
EPS Next 3Y27.3%
EPS Next 5Y20.47%
Revenue Next Year-13.31%
Revenue Next 2Y-4.05%
Revenue Next 3Y0.09%
Revenue Next 5Y1.55%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RMBL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RMBL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

RMBL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, RMBL is valued cheaply inside the industry as 98.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.11
EV/EBITDA 13.2

4.3 Compensation for Growth

A more expensive valuation may be justified as RMBL's earnings are expected to grow with 27.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.96%
EPS Next 3Y27.3%

0

5. Dividend

5.1 Amount

No dividends for RMBL!.
Industry RankSector Rank
Dividend Yield N/A

RUMBLEON INC-B

NASDAQ:RMBL (12/26/2024, 3:50:54 PM)

5.89

+0.24 (+4.25%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners42.07%
Inst Owner Change0.92%
Ins Owners0.84%
Ins Owner Change6.05%
Market Cap208.33M
Analysts84
Price Target6.63 (12.56%)
Short Float %5.64%
Short Ratio10.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.27%
Min EPS beat(2)-90.14%
Max EPS beat(2)77.59%
EPS beat(4)2
Avg EPS beat(4)-347.36%
Min EPS beat(4)-1391.61%
Max EPS beat(4)77.59%
EPS beat(8)3
Avg EPS beat(8)-284.58%
EPS beat(12)4
Avg EPS beat(12)-182.47%
EPS beat(16)5
Avg EPS beat(16)-226.62%
Revenue beat(2)0
Avg Revenue beat(2)-9.02%
Min Revenue beat(2)-13.98%
Max Revenue beat(2)-4.05%
Revenue beat(4)0
Avg Revenue beat(4)-9.17%
Min Revenue beat(4)-13.98%
Max Revenue beat(4)-4.05%
Revenue beat(8)1
Avg Revenue beat(8)-8.98%
Revenue beat(12)2
Avg Revenue beat(12)-10.6%
Revenue beat(16)4
Avg Revenue beat(16)-8.18%
PT rev (1m)0%
PT rev (3m)-5.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-65.31%
EPS NY rev (1m)-16.38%
EPS NY rev (3m)-16.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.45%
Revenue NY rev (1m)-0.96%
Revenue NY rev (3m)-1.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 5.11
P/OCF 4.25
P/B 2.5
P/tB N/A
EV/EBITDA 13.2
EPS(TTM)-8.44
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)1.15
FCFY19.56%
OCF(TTM)1.39
OCFY23.52%
SpS35.36
BVpS2.36
TBVpS-3.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.97%
ROE -228.96%
ROCE 3.3%
ROIC 1.73%
ROICexc 1.86%
ROICexgc 2.66%
OM 1.26%
PM (TTM) N/A
GM 25.43%
FCFM 3.26%
ROA(3y)-16.56%
ROA(5y)-24.4%
ROE(3y)-111.09%
ROE(5y)-245.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.21%
GM growth 5Y26.73%
F-Score5
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 5.43
Debt/FCF 12.06
Debt/EBITDA 14.97
Cap/Depr 57.1%
Cap/Sales 0.66%
Interest Coverage 0.33
Cash Conversion 162.16%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.29
Altman-Z 0.77
F-Score5
WACC10.45%
ROIC/WACC0.17
Cap/Depr(3y)83.26%
Cap/Depr(5y)107.5%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-234.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.68%
EPS Next Y91.06%
EPS Next 2Y40.96%
EPS Next 3Y27.3%
EPS Next 5Y20.47%
Revenue 1Y (TTM)-8.86%
Revenue growth 3Y48.6%
Revenue growth 5Y54.27%
Sales Q2Q%-12.75%
Revenue Next Year-13.31%
Revenue Next 2Y-4.05%
Revenue Next 3Y0.09%
Revenue Next 5Y1.55%
EBIT growth 1Y403.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1708.03%
EBIT Next 3Y276.53%
EBIT Next 5Y138.53%
FCF growth 1Y236.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y337.01%
OCF growth 3YN/A
OCF growth 5YN/A